Searchable abstracts of presentations at key conferences on calcified tissues
Bone Abstracts (2015) 4 P88 | DOI: 10.1530/boneabs.4.P88

ICCBH2015 Poster Presentations (1) (201 abstracts)

Vitamin D and bone health: A practical clinical guideline for management in children and young people in the UK

Anne Thurston 1 , Claire Bowring 1 , Nick Shaw 2 & Paul Arundel 3

1National Osteoporosis Society, Camerton, Bath and North East Somerset, UK; 2Birmingham Children’s Hospital NHS Foundation Trust, Birmingham, UK; 3Sheffield Children’s NHS Foundation Trust, Sheffield, UK.

Background: There is currently considerable clinical and academic interest in vitamin D in children and young people. This partly relates to recognition of a resurgence of symptomatic vitamin D deficiency with reports of children presenting with rickets or hypocalcaemic symptoms. An additional development has been the recognition that vitamin D may have a physiological extraskeletal role beyond its traditional function as a key regulator of calcium and bone metabolism.

Presenting problem: There is recognition that many individuals have suboptimal vitamin D status often without symptoms. One response has been a large increase in requests for measurement of vitamin D (typically serum 25OH vitamin D (25OHD)). Lack of consensus and national guidance has contributed to variation in clinical practice in the UK in terms of both testing and vitamin D treatment in children and young people.

Clinical management: Guidelines for investigation and management of vitamin D deficiency in children and young people have been produced to guide clinicians in the UK. Consistent with other UK and European guidelines, the following definitions are used:

• Serum 25OHD <25nmol/l is deficient.

• Serum 25OHD of 25-50nmol/l may be inadequate in some people.

• Serum 25OHD >50nmol/l is sufficient for almost the whole population.

The guideline recommends:

• Measurement of serum 25OHD as the best way of estimating vitamin D status.

• Testing of serum 25OHD levels should be restricted to children and young people in whom there is a clear indication.

• Primary preventive measures should be undertaken in patients at high risk of deficiency. This would include advice about safe sunlight exposure, dietary sources of vitamin D and multivitamin supplementation.

• Treatment of vitamin D deficiency should be with oral preparations of vitamin D2 or D3 given daily for 8–12 weeks.

• Many children with vitamin D deficiency will benefit from advice about dietary calcium intake.

Discussion: By publishing these guidelines we aim to provide a useful resource that will benefit patients and families, support doctors and help to ensure that finite NHS resources are appropriately targeted. The full guideline can be accessed online at:

Disclosure: Dr Arundel and Dr Shaw have both provided consultancy to Consilient Health Ltd who manufacture vitamin D preparations.

Volume 4

7th International Conference on Children's Bone Health

Salzburg, Austria
27 Jun 2015 - 30 Jun 2015


Browse other volumes

Article tools

My recent searches

No recent searches.